Trinity Biotech PE Ratio 2010-2024 | TRIB
Current and historical p/e ratio for Trinity Biotech (TRIB) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Trinity Biotech PE ratio as of June 27, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Trinity Biotech PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-27 | 0.65 | 0.00 | |
| 2024-12-31 | 0.88 | $-2.82 | 0.00 |
| 2024-09-30 | 1.10 | $-2.26 | 0.00 |
| 2024-06-30 | 2.13 | $-2.70 | 0.00 |
| 2024-03-31 | 2.04 | $-2.79 | 0.00 |
| 2023-12-31 | 2.15 | $-3.17 | 0.00 |
| 2023-09-30 | 3.68 | $-3.75 | 0.00 |
| 2023-06-30 | 4.76 | $-4.05 | 0.00 |
| 2023-03-31 | 4.70 | $-4.70 | 0.00 |
| 2022-12-31 | 4.95 | $-6.45 | 0.00 |
| 2022-09-30 | 5.36 | $-5.45 | 0.00 |
| 2022-06-30 | 6.13 | $-3.80 | 0.00 |
| 2022-03-31 | 5.30 | $-2.55 | 0.00 |
| 2021-12-31 | 7.15 | $0.45 | 15.89 |
| 2021-09-30 | 10.80 | $-0.80 | 0.00 |
| 2021-06-30 | 14.70 | $0.35 | 42.00 |
| 2021-03-31 | 18.80 | $0.60 | 31.33 |
| 2020-12-31 | 19.05 | $-0.10 | 0.00 |
| 2020-09-30 | 10.10 | $-2.90 | 0.00 |
| 2020-06-30 | 10.90 | $-4.30 | 0.00 |
| 2020-03-31 | 5.50 | $-5.25 | 0.00 |
| 2019-12-31 | 5.17 | $-5.10 | 0.00 |
| 2019-09-30 | 6.05 | $-5.35 | 0.00 |
| 2019-06-30 | 8.25 | $-5.40 | 0.00 |
| 2019-03-31 | 14.25 | $-4.35 | 0.00 |
| 2018-12-31 | 11.45 | $-4.20 | 0.00 |
| 2018-09-30 | 20.00 | $-7.60 | 0.00 |
| 2018-06-30 | 25.00 | $-7.65 | 0.00 |
| 2018-03-31 | 25.75 | $-7.60 | 0.00 |
| 2017-12-31 | 25.50 | $-7.45 | 0.00 |
| 2017-09-30 | 28.05 | $-18.10 | 0.00 |
| 2017-06-30 | 30.00 | $-18.30 | 0.00 |
| 2017-03-31 | 29.80 | $-18.05 | 0.00 |
| 2016-12-31 | 34.60 | $-18.60 | 0.00 |
| 2016-09-30 | 66.10 | $0.55 | 120.18 |
| 2016-06-30 | 56.70 | $3.30 | 17.18 |
| 2016-03-31 | 58.30 | $3.35 | 17.40 |
| 2015-12-31 | 58.80 | $4.50 | 13.07 |
| 2015-09-30 | 57.20 | $4.90 | 11.67 |
| 2015-06-30 | 90.30 | $3.15 | 28.67 |
| 2015-03-31 | 95.07 | $3.55 | 26.78 |
| 2014-12-31 | 86.47 | $3.60 | 24.02 |
| 2014-09-30 | 90.23 | $3.65 | 24.72 |
| 2014-06-30 | 113.73 | $2.10 | 54.16 |
| 2014-03-31 | 118.55 | $2.05 | 57.83 |
| 2013-12-31 | 123.00 | $2.05 | 60.00 |
| 2013-09-30 | 106.46 | $2.10 | 50.70 |
| 2013-06-30 | 82.44 | $3.75 | 21.98 |
| 2013-03-31 | 81.62 | $3.85 | 21.20 |
| 2012-12-31 | 69.72 | $3.90 | 17.88 |
| 2012-09-30 | 60.78 | $3.80 | 15.99 |
| 2012-06-30 | 58.02 | $3.70 | 15.68 |
| 2012-03-31 | 50.90 | $3.60 | 14.14 |
| 2011-12-31 | 48.56 | $3.50 | 13.88 |
| 2011-09-30 | 43.70 | $3.45 | 12.67 |
| 2011-06-30 | 47.42 | $3.25 | 14.59 |
| 2011-03-31 | 42.96 | $14.40 | 2.98 |
| 2010-12-31 | 40.35 | $14.30 | 2.82 |
| 2010-09-30 | 28.99 | $14.20 | 2.04 |
| 2010-06-30 | 27.85 | $14.20 | 1.96 |
| 2010-03-31 | 24.96 | $2.90 | 8.61 |
| 2009-12-31 | 18.50 | $2.75 | 6.73 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.012B | $0.062B |
| Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.799B | 28.11 |
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |